<DOC>
	<DOCNO>NCT01406795</DOCNO>
	<brief_summary>To study safety efficacy drug coat stent treatment venous occlusion stenosis low extremity . The use device treatment peripheral arterial disease approve FDA , however , use device venous occlusion stenosis , although perform practitioner , yet study detail .</brief_summary>
	<brief_title>The GORE Viabahn Endoprosthesis Treatment Venous Occlusions Stenoses</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patient least 18 year old Patient clinical manifestation ( i.e . symptom and/or sign ) chronic DVT extremity . The Venous Clinical Severity Score ( VCSS ) use determine patient currently suffer chronic DVT , VCSS score 4 great necessary inclusion . Imaging confirmation venous occlusion stenosis ( &gt; 50 % ) involve femoral , and/or popliteal vein Obstructed vessel caliber accommodate 7FR System , insertion site target segment Patient able read answer questionnaire English History lifethreatening reaction contrast material Unwilling unable provide inform consent , return require followup evaluation Participating another investigational study complete followup testing Can receive outpatient anticoagulation LMWH and/or vitamin K antagonist ( VKAs ) Absolute contraindication contrast medium renal insufficiency ( baseline creatinine &gt; 2.0 mg/dL ) . Either history presence heparininduced thrombocytopenia antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Post Thrombotic Syndrome</keyword>
	<keyword>Venous Stasis</keyword>
	<keyword>Venous Occlusions</keyword>
	<keyword>Venous Stenosis</keyword>
</DOC>